Serum C-X-C motif ligand 4 (CXCL4) levels were elevated in SSc patients with both PAH and ILD [150], whereas high serum levels of CXCL16 were found in SSc-PAH patients [151]. This evidence concerns the gene CXCL16 and systemic sclerosis.